Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Current Leases (2017 - 2024)

KalVista Pharmaceuticals' Current Leases history spans 7 years, with the latest figure at $1.5 million for Q4 2024.

  • For Q4 2024, Current Leases changed N/A year-over-year to $1.5 million; the TTM value through Dec 2024 reached $1.5 million, changed N/A, while the annual FY2024 figure was $1.3 million, N/A changed from the prior year.
  • Current Leases for Q4 2024 was $1.5 million at KalVista Pharmaceuticals, up from $1.4 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.5 million in Q4 2024 and bottomed at $422000.0 in Q4 2020.
  • The 4-year median for Current Leases is $1.1 million (2023), against an average of $968833.3.
  • The largest YoY upside for Current Leases was 988.89% in 2020 against a maximum downside of 29.9% in 2020.
  • A 4-year view of Current Leases shows it stood at $422000.0 in 2020, then soared by 40.28% to $592000.0 in 2021, then surged by 93.92% to $1.1 million in 2023, then rose by 26.48% to $1.5 million in 2024.
  • Per Business Quant, the three most recent readings for KALV's Current Leases are $1.5 million (Q4 2024), $1.4 million (Q4 2024), and $1.3 million (Q3 2024).